Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.
Stocktwits·3mo ago
More News
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu Traws Pharma Announces...
PR Newswire·8mo ago
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program PR Newswire SAN DIEGO, Jan...
PR Newswire·9mo ago
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval Traws Pharma, Inc...
The U.S. has reported H5N1 Bird Flu 64 infections since April, with dairy herds in 16 states affected.
Stocktwits·9mo ago
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu PR Newswire NEWTOWN, Pa., Dec...
PR Newswire·9mo ago
Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza Treatment
Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza Treatment Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir...
PR Newswire·1y ago
Earnings Scheduled For April 16, 2024
Companies Reporting Before The Bell
Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter.
read more...
Benzinga·1y ago
Traws Pharma Announces New Employee Inducement Grants
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, Traws , the Company ) today announced it has granted equity awards to new employees who joined Traws in...